Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$656M |
| 2 |
S&P Global
SPGI
|
+$588M |
| 3 |
Tesla
TSLA
|
+$386M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$561M |
| 2 |
United Therapeutics
UTHR
|
+$499M |
| 3 |
Flutter Entertainment
FLUT
|
+$445M |
| 4 |
WRK
WestRock Company
WRK
|
+$308M |
| 5 |
Visa
V
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18% |
| 2 | Consumer Discretionary | 6.63% |
| 3 | Financials | 5.84% |
| 4 | Healthcare | 4.98% |
| 5 | Industrials | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
3001
CALL
DELISTED
Avidity Biosciences
RNAM
| $1.24M | ﹤0.01% |
+27,000
| New | +$1.17M |
|
|
RNAM
3002
PUT
DELISTED
Avidity Biosciences
RNAM
| $1.24M | ﹤0.01% |
+27,000
| New | +$1.17M |
|
3003
Pegasystems
PEGA
$4.89B
| $1.24M | ﹤0.01% |
33,896
-4,126
| -11% | -$136K |
|
3004
MannKind Corp
MNKD
$1.22B
| $1.24M | ﹤0.01% |
196,717
+92,374
| +89% | +$531K |
|
3005
PUT
Nutrien
NTR
$33.3B
| $1.24M | ﹤0.01% |
25,700
-76,700
| -75% | -$3.7M |
|
|
HTT
3006
High Templar Tech Ltd
HTT
$376M
| $1.24M | ﹤0.01% |
580,417
-20,643
| -3% | -$38.2K |
|
|
HSII
3007
DELISTED
Heidrick & Struggles
HSII
| $1.24M | ﹤0.01% |
31,808
+15,280
| +92% | +$552K |
|
3008
CALL
US Bancorp
USB
$98B
| $1.23M | ﹤0.01% |
27,000
-500,000
| -95% | -$21.9M |
|
3009
Sensata Technologies
ST
$6.83B
| $1.23M | ﹤0.01% |
34,424
-11,217
| -25% | -$418K |
|
3010
Vanguard S&P 500 Growth ETF
VOOG
$25.6B
| $1.23M | ﹤0.01% |
21,432
+8,508
| +66% | +$472K |
|
3011
PC Connection
CNXN
$2.1B
| $1.23M | ﹤0.01% |
16,352
+2,430
| +17% | +$169K |
|
3012
CALL
Mercado Libre
MELI
$94.3B
| $1.23M | ﹤0.01% |
600
-2,100
| -78% | -$3.95M |
|
3013
First American
FAF
$7.65B
| $1.23M | ﹤0.01% |
18,645
+7,428
| +66% | +$453K |
|
3014
Shutterstock
SSTK
$195M
| $1.22M | ﹤0.01% |
34,555
+17,081
| +98% | +$630K |
|
3015
CALL
Arbutus Biopharma
ABUS
$849M
| $1.22M | ﹤0.01% |
317,400
+32,400
| +11% | +$124K |
|
|
3016
PUT
Arbutus Biopharma
ABUS
$849M
| $1.22M | ﹤0.01% |
317,400
+32,400
| +11% | +$124K |
|
3017
Helios Technologies
HLIO
$2.6B
| $1.22M | ﹤0.01% |
25,576
+18,252
| +249% | +$802K |
|
3018
First Advantage
FA
$3.36B
| $1.22M | ﹤0.01% |
61,348
+40,248
| +191% | +$718K |
|
3019
CALL
Globalstar
GSAT
$10.7B
| $1.22M | ﹤0.01% |
65,460
-46,000
| -41% | -$851K |
|
3020
Warner Music
WMG
$13.6B
| $1.21M | ﹤0.01% |
38,737
+9,534
| +33% | +$282K |
|
|
SHOE
3021
Shoe Station Group
SHOE
$415M
| $1.21M | ﹤0.01% |
27,641
+11,927
| +76% | +$487K |
|
3022
Empire State Realty Trust
ESRT
$867M
| $1.21M | ﹤0.01% |
109,220
+51,924
| +91% | +$542K |
|
3023
OneSpaWorld
OSW
$2.6B
| $1.21M | ﹤0.01% |
73,270
+50,671
| +224% | +$802K |
|
3024
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.21M | ﹤0.01% |
17,200
-12,800
| -43% | -$1.07M |
|
3025
Dole
DOLE
$1.35B
| $1.21M | ﹤0.01% |
74,202
+52,754
| +246% | +$788K |
|
Similar funds
Citigroup's Q3 2024 Portfolio in Review
As of Q3 2024, Citigroup held 5,895 positions worth $173B, up 11% from $156B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup deployed $7.75B of net new capital in Q3 2024, opening 351 new positions and adding to 3,206 existing holdings. Its largest new stake was Smurfit Westrock: 1,562,261 shares worth $77.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $561M trimmed.
- Citigroup's largest Q3 2024 buy was Smurfit Westrock: 1,562,261 shares worth $77.2M.
- Citigroup added most to Caterpillar in Q3 2024, an estimated $656M increase.
- Citigroup's biggest Q3 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $561M.
- Citigroup fully exited WestRock Company in Q3 2024, selling an estimated $308M.
- Citigroup's ten largest holdings make up 21% of its $173B portfolio in Q3 2024.
- Citigroup opened 351 new positions and closed 235 in Q3 2024.
- Citigroup's portfolio value rose 11% quarter-over-quarter to $173B.
Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.